Follow


Submissions from 2017

PDF

Optimizing Medication Appropriateness in Older Adults: A Randomized Clinical Interventional Trial to Decrease Anticholinergic Burden, Daniela C. Moga, Erin L. Abner, Dorinda N. Rigsby, Lynne Eckmann, Mark Huffmyer, Richard R. Murphy, Beth B. Coy, and Gregory A. Jicha

Submissions from 2016

PDF

Incidence and Risk Factors of Thromboembolism with Multiple Myeloma in the Presence of Death as a Competing Risk: An Empirical Comparison of Statistical Methodologies, Joshua D. Brown and Val R. Adams

PDF

The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population, Joshua D. Brown, Nathan J. Pauly, and Jeffery C. Talbert

PDF

Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery, Sara E. Parli, Melissa L. Thompson Bastin, and Daniel A. Lewis

PDF

National Trends in Off-Label Use of Atypical Antipsychotics in Children and Adolescents in the United States, Minji Sohn, Daniela C. Moga, Karen Blumenschein, and Jeffery Talbert

Submissions from 2015

PDF

Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy, Megan E. Kunka, Elizabeth A. Cady, Heejung C. Woo, and Melissa L. Thompson Bastin

PDF

A Coming Disruption in Pharmacy?, Frank Romanelli and Timothy S. Tracy

PDF

Utilizing Monte Carlo Simulations to Optimize Institutional Empiric Antipseudomonal Therapy, Sarah J. Tennant, Donna R. Burgess, Jeffrey M. Rybak, Craig A. Martin, and David S. Burgess

PDF

Prescription Drug Monitoring Program Utilization in Kentucky Community Pharmacies, Sarah E. Wixson, Karen Blumenschein, Amie J. Goodin, Jeffery Talbert, and Patricia R. Freeman

PDF

Azithromycin Drives Alternative Macrophage Activation and Improves Recovery and Tissue Sparing in Contusion Spinal Cord Injury, Bei Zhang, William M. Bailey, Timothy J. Kopper, Michael B. Orr, David J. Feola, and John C. Gensel

Submissions from 2014

PDF

Pharmacy Law Brief: Alternative Dispute Resolution, Joseph L. Fink III

PDF

Pharmacy Law Brief: Implications of Being a Specialist, Joseph L. Fink III

PDF

Pharmacy Law Brief: Medications and Lawful Executions, Joseph L. Fink III

PDF

Pharmacy Law Brief: The Federal False Claims Act, Joseph L. Fink III

PDF

A Word of Caution Regarding Proposed Benefits of Albumin from ALBIOS: A Dose of Healthy Skepticism, Alexander H. Flannery, Sean P. Kane, and Angel O. Coz-Yataco

Submissions from 2013

PDF

Pharmacy Law Brief: Contemporary Legal Issues for Leadership in Non-Profits - III, Joseph L. Fink III

PDF

Pharmacy Law Brief: Contemporary Legal Issues for Leadership in Non-Profits - IV, Joseph L. Fink III

PDF

Pharmacy Law Brief: Exclusion of Practitioners from Federally Funded Health Programs, Joseph L. Fink III

PDF

Pharmacy Law Brief: National Practitioner Data Bank - What Is It?, Joseph L. Fink III

PDF

Pharmacy Law Brief: Pharmacy Law Exam for Licensure, Joseph L. Fink III

PDF

Clinical Inertia in Type 2 Diabetes: A Retrospective Analysis of Pharmacist-Managed Diabetes Care vs. Usual Medical Care, Felix K. Yam, Aimee G. Adams, Holly Divine, Douglas Steinke, and Mikael D. Jones

Submissions from 2012

PDF

Academics-Athletics Forums: An Initiative to Improve Communication and Understanding across the University, Joseph L. Fink III

PDF

Pharmacy Law Brief: Contemporary Legal Issues for Leadership in Non-Profits - I, Joseph L. Fink III

PDF

Pharmacy Law Brief: Contemporary Legal Issues for Leadership in Non-Profits - II, Joseph L. Fink III

PDF

Chain Community Pharmacists' Willingness, Attitudes, and Barriers in Providing Self-Care Medication and Supplement Recommendations, Clark Kebodeaux, William M. Grise, Brooke Hudspeth, and Holly Divine